| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Altered phenotype in LMAN1-deficient mice with low levels of residual LMAN1 expression
|
Everett, Lesley A.
|
|
|
4 |
22 |
p. 5635-5643
|
artikel
|
| 2 |
A new role of glutathione peroxidase 4 during human erythroblast enucleation
|
Ouled-Haddou, Hakim
|
|
|
4 |
22 |
p. 5666-5680
|
artikel
|
| 3 |
A risk model for relapsed/refractory aggressive NHL integrating clinical risk factors and pretransplant Deauville score
|
Yhim, Ho-Young
|
|
|
4 |
22 |
p. 5762-5771
|
artikel
|
| 4 |
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
|
Wu, Ye-Jun
|
|
|
4 |
22 |
p. 5846-5857
|
artikel
|
| 5 |
Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients
|
Ilett, Emma E.
|
|
|
4 |
22 |
p. 5797-5809
|
artikel
|
| 6 |
C(h)AR-ting a new course in incurable lymphomas: CAR T cells for mantle cell and follicular lymphomas
|
Jacobson, Caron A.
|
|
|
4 |
22 |
p. 5858-5862
|
artikel
|
| 7 |
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myeloma
|
Bruno, Tiziana
|
|
|
4 |
22 |
p. 5616-5630
|
artikel
|
| 8 |
Cho S-F, Lin L, Xing L, et al. The immunomodulatory drugs lenalidomide and pomalidomide enhance the potency of AMG 701 in multiple myeloma preclinical models. Blood Adv. 2020;4(17):4195-4207.
|
|
|
|
4 |
22 |
p. 5772
|
artikel
|
| 9 |
Combining T-cell–specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors
|
Frank, Annika M.
|
|
|
4 |
22 |
p. 5702-5715
|
artikel
|
| 10 |
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis
|
Gerds, Aaron T.
|
|
|
4 |
22 |
p. 5825-5835
|
artikel
|
| 11 |
Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis
|
Noy, Ariela
|
|
|
4 |
22 |
p. 5773-5784
|
artikel
|
| 12 |
Editorial Board
|
|
|
|
4 |
22 |
p. i
|
artikel
|
| 13 |
Enhancing therapeutic efficacy of in vivo platelet-targeted gene therapy in hemophilia A mice
|
Wang, Xuefeng
|
|
|
4 |
22 |
p. 5722-5734
|
artikel
|
| 14 |
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease
|
Nann, Dominik
|
|
|
4 |
22 |
p. 5652-5665
|
artikel
|
| 15 |
Fundamentals of immunology for understanding immunotherapy for lymphoma
|
Ansell, Stephen M.
|
|
|
4 |
22 |
p. 5863-5867
|
artikel
|
| 16 |
Late-onset and long-lasting autoimmune neutropenia: an analysis from the Italian Neutropenia Registry
|
Fioredda, Francesca
|
|
|
4 |
22 |
p. 5644-5649
|
artikel
|
| 17 |
Luque Paz D, Jouanneau-Courville R, Riou J, et al. Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation. Blood Adv. 2020;4(19):4887-4897.
|
|
|
|
4 |
22 |
p. 5651
|
artikel
|
| 18 |
Macrophage protease-activated receptor 2 regulates fetal liver erythropoiesis in mice
|
Saffarzadeh, Mona
|
|
|
4 |
22 |
p. 5810-5824
|
artikel
|
| 19 |
Malignant progression of donor-engrafted clonal hematopoiesis in sibling recipients after stem cell transplantation
|
Nevejan, Louis
|
|
|
4 |
22 |
p. 5631-5634
|
artikel
|
| 20 |
Mariotti J, Raiola AM, Evangelista A, et al. Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy. Blood Adv. 2020;4(16):3900-3912.
|
|
|
|
4 |
22 |
p. 5650
|
artikel
|
| 21 |
Mesenchymal stromal cells in hematopoietic cell transplantation
|
Burnham, Andre J.
|
|
|
4 |
22 |
p. 5877-5887
|
artikel
|
| 22 |
Next-generation cell therapies: the emerging role of CAR-NK cells
|
Basar, Rafet
|
|
|
4 |
22 |
p. 5868-5876
|
artikel
|
| 23 |
Paroxysmal nocturnal hemoglobinuria caused by CN-LOH of constitutional PIGB mutation and 70-kbp microdeletion on 15q
|
Langemeijer, Saskia
|
|
|
4 |
22 |
p. 5755-5761
|
artikel
|
| 24 |
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
|
Vercellino, Laetitia
|
|
|
4 |
22 |
p. 5607-5615
|
artikel
|
| 25 |
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
|
Short, Nicholas J.
|
|
|
4 |
22 |
p. 5681-5689
|
artikel
|
| 26 |
Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome
|
Bawany, Fatima
|
|
|
4 |
22 |
p. 5698-5701
|
artikel
|
| 27 |
Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial
|
Rana, Ritika
|
|
|
4 |
22 |
p. 5836-5845
|
artikel
|
| 28 |
SF3B1-mutant CMML defines a predominantly dysplastic CMML subtype with a superior acute leukemia–free survival
|
Wudhikarn, Kitsada
|
|
|
4 |
22 |
p. 5716-5721
|
artikel
|
| 29 |
The effect of red blood cell transfusion on fatigability after hospital discharge
|
Prochaska, Micah T.
|
|
|
4 |
22 |
p. 5690-5697
|
artikel
|
| 30 |
The prospective Hemophilia Inhibitor PUP Study reveals distinct antibody signatures prior to FVIII inhibitor development
|
Reipert, B.M.
|
|
|
4 |
22 |
p. 5785-5796
|
artikel
|
| 31 |
Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin
|
Marcellino, Bridget K.
|
|
|
4 |
22 |
p. 5735-5744
|
artikel
|
| 32 |
Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients
|
Nelson, Adam S.
|
|
|
4 |
22 |
p. 5745-5754
|
artikel
|
Tijdschrift beschrijving